» Articles » PMID: 18947160

Dexmedetomidine: a Useful Adjunct to Consider in Some High-risk Situations

Overview
Journal AANA J
Specialties Anesthesiology
Nursing
Date 2008 Oct 25
PMID 18947160
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Dexmedetomidine is a relatively selective alpha2 agonist with sympatholytic, sedative, amnestic, and analgesic properties. It is indicated for the short-term sedation of patients needing mechanical ventilation in the intensive care unit. Recent reports have been published describing dexmedetomidine as a useful adjunct in both regional and general anesthesia. A few case studies have demonstrated successful use of dexmedetomidine as a replacement agent for opioids in patients in whom airway compromise was a concern. This article will provide the reader with a comprehensive review of the pharmacology, pharmacokinetics, and adverse effects of dexmedetomidine. A thorough understanding of this drug will enable the anesthesia provider to determine situations in which dexmedetomidine may be a useful drug to consider, whether as an adjunct or as a sole agent.

Citing Articles

Impact of Dexmedetomidine on Hemodynamics, Plasma Catecholamine Levels, and Delirium Incidence Among Intubated Patients in the ICU--A Randomized Controlled Trial.

Qiao L, Wang Z, Shen J, Xing X, Yuan H Ther Clin Risk Manag. 2024; 20:689-700.

PMID: 39372263 PMC: 11451452. DOI: 10.2147/TCRM.S471229.


Preoperative preparation and premedication of bariatric surgical patient.

Varbanova M, Maggard B, Lenhardt R Saudi J Anaesth. 2022; 16(3):287-298.

PMID: 35898527 PMC: 9311181. DOI: 10.4103/sja.sja_140_22.


Evaluation of postoperative analgesic efficacy and perioperative hemodynamic changes with low dose intravenous dexmedetomidine infusion in patients undergoing laparoscopic cholecystectomy - A randomised, double-blinded, placebo-controlled trial.

Chilkoti G, Karthik G, Rautela R J Anaesthesiol Clin Pharmacol. 2020; 36(1):72-77.

PMID: 32174662 PMC: 7047684. DOI: 10.4103/joacp.JOACP_184_17.


Dexmedetomidine: present and future directions.

Lee S Korean J Anesthesiol. 2019; 72(4):323-330.

PMID: 31220910 PMC: 6676029. DOI: 10.4097/kja.19259.


Comparison of dexmedetomidine vs. remifentanil combined with sevoflurane during radiofrequency ablation of hepatocellular carcinoma: a randomized controlled trial.

Pan J, Li X, He Y, Jian C, Chen H, Hei Z Trials. 2019; 20(1):28.

PMID: 30621749 PMC: 6326039. DOI: 10.1186/s13063-018-3010-z.